Latest Breaking News On - Outcomes model - Page 1 : comparemela.com

Costs of SGLT2 inhibitors and GLP-1 receptor agonists need to be lowered substantially to improve health outcomes and prevent health disparities in patients with type 2 diabetes, say researchers.

United statesUniversity of chicagoUnited kingdomJing choiNeda laiteerapongNutrition examination surveyNational healthDrug administrationChronic disease researchMedscape medical newsAffordable insulin now actPrices too highEncourage first lineUnited kingdom prospective diabetes studyOutcomes modelCould remain